Clearpoint neuro, inc. (MRIC)

CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities:
Net loss

-6,373

-5,539

-5,112

-5,417

-5,743

-6,163

-7,027

-7,024

-7,152

-7,167

-6,766

-7,904

-7,681

-8,069

-7,587

-5,269

-6,547

-8,449

-9,165

-12,567

-11,100

-4,524

-4,325

-3,873

-3,632

-7,086

-4,412

-3,979

-3,227

-5,877

-8,691

-8,065

-9,535

-8,311

0

0

0

Adjustments to reconcile net loss to net cash flows from operating activities:
Depreciation

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

0

-

-

-

0

-

-

-

-

116

123

132

150

155

183

163

166

211

236

308

371

377

374

400

404

426

453

435

432

416

415

428

382

354

0

0

0

Share-based compensation

874

799

838

980

1,136

1,231

1,598

1,423

1,286

1,245

1,066

1,117

1,133

1,187

997

1,028

1,564

1,682

1,746

1,669

1,078

880

1,011

1,179

1,319

1,458

1,383

1,536

2,119

2,031

1,883

1,618

965

989

0

0

0

Expenses paid through the issuance of common stock

-

-

-

-

-

77

77

77

579

502

304

334

-129

62

298

304

300

145

144

146

149

411

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Gain on change in fair value of derivative liabilities

-

-

-

-

-

64

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain from change in fair value of derivative liabilities

-

-

-

-

-

-

-

-

-

-

365

580

812

1,065

1,306

2,933

2,482

1,539

1,952

-778

283

1,549

936

466

546

1,686

0

0

0

-

-

-

-

-

-

-

-

Gain on sale of intellectual property

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,338

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Loss on loan modification

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,356

0

0

0

-

-

-

-

-

-

-

-

Amortization of debt issuance costs and original issue discounts

1,347

729

677

653

595

562

533

497

462

426

403

390

373

424

451

482

512

471

439

411

384

330

282

232

188

143

99

56

14

2,061

2,374

2,769

3,098

1,359

0

0

0

Amortization of lease right of use, net of accretion in lease liabilities

106

106

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase (decrease) in cash resulting from changes in:
Accounts receivable

-281

-143

1,073

601

356

284

191

20

-99

83

60

-18

-487

-352

-33

282

891

749

288

-111

153

-301

-238

158

68

324

601

270

225

43

353

161

135

370

0

0

0

Inventory, net

611

1,024

582

-258

-371

-122

362

739

705

469

205

47

207

-72

49

-308

-396

-68

-395

234

308

345

611

350

301

309

389

421

406

270

104

202

14

-91

0

0

0

Prepaid expenses and other current assets

-11

143

102

109

46

20

22

51

57

57

45

11

-19

37

60

101

79

68

85

107

-35

-145

-116

-85

8

63

-12

11

-41

43

103

49

24

3

0

0

0

Other assets

-73

-14

-0

-0

-20

10

-0

-0

14

0

0

0

0

-

-

201

44

-9

9

15

2

0

0

0

0

-

-

-

-38

-16

0

0

0

-

-

-

-

Accounts payable and accrued expenses

1,153

1,165

1,583

629

68

-284

-603

-430

-1,018

-512

128

92

130

178

121

256

-397

-436

-838

-419

1,242

1,143

1,186

658

28

-695

-1,398

-2,034

-3,215

-2,738

-1,455

-161

1,147

2,244

0

0

0

Accrued interest

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease liabilities

-105

-108

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

326

863

676

525

462

94

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

59

203

111

107

56

149

53

13

71

39

-27

-4

-16

-41

125

-655

-1,936

-2,620

-3,346

-3,233

-2,600

-2,600

-2,600

-2,600

0

0

0

Net cash flows from operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6,213

-7,447

-8,637

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash flows from operating activities

-4,570

-2,849

-2,966

-2,977

-3,279

-4,630

-5,793

-6,499

-6,607

-5,992

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-6,894

-7,777

-8,490

-8,610

-7,792

-7,433

-6,643

-6,012

-6,555

-6,239

0

0

0

Cash flows from investing activities:
Purchases of property and equipment

-

-

-

-

-

63

64

75

47

26

25

3

23

101

105

169

147

76

108

50

52

48

12

24

68

74

107

98

130

127

0

0

0

-

-

-

-

Acquisition of licensing rights

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash flows from investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-169

-147

-76

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash flows from investing activities

0

-

-

-

-

-63

-64

-75

-47

-26

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-168

-174

-207

-98

-130

-127

0

0

0

-

-

-

-

Cash flows from financing activities:
Proceeds from issuance of 2020 senior secured convertible notes, net of financing costs and discount

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net proceeds from issuance of convertible notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,424

0

0

0

-

-

-

-

Proceeds from private equity offering

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of 2015 private placement financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from stock option and warrant exercises

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

143

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash flows from financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,879

4,739

4,879

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of warrants

-

-

-

-

-

505

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayment of 2010 junior secured notes payable

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash flows from financing activities

0

-

-

-

-

-1,494

-1,459

531

12,198

11,993

0

0

0

-

-

-

-

-

-

-

-

-

-

-

3,665

9,848

9,942

14,463

15,439

9,035

0

0

0

-

-

-

-

Net change in cash and cash equivalents

14,484

2,594

2,524

764

-5,021

-6,188

-7,318

-6,043

5,544

5,974

6,596

10,724

-1,612

-2,092

2,580

-1,503

-2,856

-3,835

-42

-556

637

5,727

-3,136

-2,901

-3,397

1,896

1,243

5,754

7,516

1,474

3,717

625

1,673

-1,431

0

0

0

SUPPLEMENTAL CASH FLOW INFORMATION
Cash paid for:
Income taxes

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Interest

1,068

316

201

228

355

210

294

348

348

348

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-Cash Transactions
Financing costs

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

962

223

223

223

223

446

223

224

2

6

11

17

30

38

33

26

11

0

0

0

0

0

Transfer from inventory to property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

55

13

120

114

94

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-